Advancement in treatment and diagnosis of pancreatic cancer with radiopharmaceuticals

作     者：yu-ping xu min yang 

作者机构：key laboratory of nuclear medicineministry of healthjiangsu key laboratory of molecular nuclear medicinejiangsu institute of nuclear medicineWuxi 214063Jiangsu ProvinceChina 

出 版 物：《World Journal of Gastrointestinal Oncology》 (世界胃肠肿瘤学杂志（英文版）（电子版）)

年 卷 期：2016年第8卷第2期

页      面：165-172页

核心收录：

学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

基　　金：Supported by National Natural Science Foundation,Nos.81171399,51473071,81101077,21401084,81401450 and 81472749 Jiangsu Province Foundation,Nos.BE2014609,BE2012622,BL2012031 and BM2012066 Wuxi Foundation,No.CSZ0N1320 

主　　题：Pancreatic cancer Diagnosis Therapy Radiopharmaceuticals Positron emission tomography 

摘      要：Pancreatic cancer(PC) is a major health problem. Conventional imaging modalities show limited accuracy for reliable assessment of the tumor. Recent researches suggest that molecular imaging techniques with tracers provide more biologically relevant information and are benefit for the diagnosis of the cancer. In addition,radiopharmaceuticals also play more important roles in treatment of the disease. This review summaries the advancement of the radiolabeled compounds in the theranostics of PC.